Recorded April 16, 2020 | On-Demand Webinar
Define biosimilars. Discuss the approval standards of Biologics License Applications (BLAs). Explore exclusivity issues and the “Patent Dance”.
This session was recorded as part of FDLI’s virtual Introduction to Drug Law and Regulation course in April 2020.